National
Tom Gallagher, U.S. Foreign Service officer, dies at 77
Longtime LGBT rights advocate came out publicly in 1975
Tom Gallagher
Tom Gallagher, who became the first known U.S. Foreign Service officer to come out as gay in 1975 and who switched careers to become a social worker before returning to the Foreign Service in 1994, died July 8 in his hometown of Tinton Falls, N.J. from complications associated with a bacterial infection. He was 77.
In a write-up of his life and career that he prepared shortly before his passing and in an earlier interview published in the online publication Slate, he said he decided to disclose his sexual orientation at a 1975 conference in Washington, D.C., organized by the then Gay Activists Alliance called Gays and the Federal Government.
Knowing the disclosure would jeopardize his then 10-year career at the State Department and Foreign Service, he decided to come out because he became tired of having to conceal the truth of who he was, he recounted in the interview.
One year later, in 1976, after he determined longstanding policies making it difficult if not impossible for gays working in the Foreign Service to retain their required security clearances, he resigned and moved to California, where he began a new career as a social worker
His biographical write-up says he was born Sept. 11, 1940 in Manhattan before his family moved to New Jersey. He graduated from Holy Spirit School and Red Bank Catholic High School in Asbury Park, N.J. before entering New Jersey’s Monmouth University, where he received a bachelor’s degree in 1962.
Five days after graduating from Monmouth he signed up as a Peace Corps volunteer and entered the first Peace Corps group to go to Ethiopia, his biographical write-up says. After completing a Peace Corps training program at Georgetown University he and his group of volunteers were invited to the White House, where President John F. Kennedy and first lady Jacqueline Kennedy hosted a send-off tea party.
According to his write-up, upon their arrival in Addis Ababa, Ethiopia, the Peace Corps group was welcomed by Emperor Haile Selassie, the country’s monarch and leader. A month after arriving in the city of Agordot for his assignment to teach a seventh grade history class, Gallagher recounted he heard the “first shot” of what became the province of Eritrea’s protracted war of independence.
His write-up says he “remained devoted to Eritrea and its people for the rest of his life” and “sixty years after leaving the Peace Corps Tom was still in touch with 13 of the 80 boys he taught in Agordot.”
Upon returning to the U.S. he began his first full salaried job at the White House where he worked for President Lyndon Johnson’s War on Poverty program. It was at that time that he met Carolyn Worrell, the bright young woman also interested in foreign affairs whom he married a short time later.
In his Slate interview with freelance journalist Jacqui Shine he said he believed he was in love with Worrell at a time when he was struggling within himself to fight what he always knew deep inside himself – that he liked men. He had “fooled around with boys” since he was a teenager growing up on the New Jersey shore, he said in the interview.
Gallagher began his first stint in the Foreign Service in 1965, with his first overseas assignment sending him to Jidda, Saudi Arabia.
Subsequent assignments took him to Nigeria and Ecuador, where he served as acting U.S. Consul General in the city of Guayaquil, becoming, at age 34, the youngest ever chief of a major U.S. diplomatic mission. He later returned to Washington where he served in various positions at the State Department headquarters before coming out at the gay conference.
In 1970, shortly after completing his tour in Nigeria, he told his wife he wanted a divorce and arranged for the couple to stay together until Worrell found a job with a federal agency and got “settled,” he said in the Slate interview. It wasn’t until years later that he told his then ex-wife that the marriage breakup was due to his struggle with his sexual orientation, he said in the interview.
Meanwhile, after resigning from the Foreign Service in 1976 he moved to California and underwent training to become a social worker. A short time later he began work in the first of a number of positions, including a post as an emergency room social worker at UCLA Hospital in Los Angeles. He also volunteered as director of counseling programs at the Gay Community Services Center in LA.
Other positions he held included supervisor for the Travelers Aid Society in San Francisco; director of a Napa County, Calif., psychiatric emergency program; and as a volunteer for AIDS programs in the state.
In 1994, when President Bill Clinton removed policies preventing gays from working in the Foreign Service, Gallagher returned to his earlier career as a Foreign Service officer, his write up says. His first assignment was that of the position of American Consul at the U.S. Embassy in Madrid, Spain. While holding that post Gallagher helped raise $3 million for the Spanish AIDS Foundation.
Following his post in Spain he was appointed as Country Officer for Eritrea and Sudan in the State Department’s Office of East African Affairs. In 1999, he became head of the visa section at the U.S. Embassy in Brussels, where he was credited with refusing a visa for a radical Moroccan who was linked to a terrorist organization considering a plot to spray poison on a U.S. city, according to his biographical write-up.
The write-up says he next returned to Washington and worked at the State Department’s Office of Central African Affairs where he served as Country Officer for the Republic of the Congo. His final tour at the State Department was with the Office of International Health, where he served as Regional Advisor for Europe and worked on an international AIDS program.
After retiring in 2005, Gallagher continued to take on short tours for the State Department including assignments at 17 embassies and consulates on five continents, the write-up says. He also taught a course on the Middle East as an Adjunct Professor of Political Science at Monmouth University.
In 2012, during an event at the State Department celebrating the 20th anniversary of the State Department’s LGBT employee group, to which Gallagher was invited, then Secretary of State Hillary Clinton talked about Gallagher’s role in advocating for LGBT equality when he came out as a Foreign Service officer in 1975.
“I don’t want any of you who are a lot younger ever to take for granted what it took for people like Tom Gallagher to pave the way for all of you,” Clinton told the gathering. “It’s not a moment to be nostalgic,” she said. “It’s a moment for us to remember and to know that all of the employees who sacrificed their right to be who they are were really defending your rights and the rights and freedoms of others at home and abroad.”
Shine, who conducted the Slate interview, said she got to know Gallagher when she interviewed him for another story about three years ago.
“I was very fond of Tom, who was very funny, sweet, and a hell of a storyteller,” she told the Washington Blade. “He was as astonished as anyone by the extraordinary turns his life took, and humbled by and grateful for all he experienced.”
Gallagher is survived by his former wife, Carolyn Worrell, who is now a judge in Nevada; and his husband, Amin Dulgumoni, a senior software engineer at Goldman Sachs.
Plans for a memorial were expected to be announced soon.
A Wider Bridge on Friday announced it will shut down at the end of the month.
The group that “mobilizes the LGBTQ community to fight antisemitism and support Israel and its LGBTQ community” in a letter to supporters said financial challenges prompted the decision.
“After 15 years of building bridges between LGBTQ communities in North America and Israel, A Wider Bridge has made the difficult decision to wind down operations as of Dec. 31, 2025,” it reads.
“This decision comes after challenging financial realities despite our best efforts to secure sustainable funding. We deeply appreciate our supporters and partners who made this work possible.”
Arthur Slepian founded A Wider Bridge in 2010.
The organization in 2016 organized a reception at the National LGBTQ Task Force’s Creating Change Conference in Chicago that was to have featured to Israeli activists. More than 200 people who protested against A Wider Bridge forced the event’s cancellation.
A Wider Bridge in 2024 urged the Capital Pride Alliance and other Pride organizers to ensure Jewish people can safely participate in their events in response to an increase in antisemitic attacks after Hamas militants attacked Israel on Oct. 7, 2023.
The Jewish Telegraphic Agency reported authorities in Vermont late last year charged Ethan Felson, who was A Wider Bridge’s then-executive director, with lewd and lascivious conduct after alleged sexual misconduct against a museum employee. Rabbi Denise Eger succeeded Felson as A Wider Bridge’s interim executive director.
A Wider Bridge in June honored U.S. Rep. Debbie Wasserman Schultz (D-Fla.) at its Pride event that took place at the Capital Jewish Museum in D.C. The event took place 15 days after a gunman killed two Israeli Embassy employees — Yaron Lischinsky and Sarah Milgrim — as they were leaving an event at the museum.
“Though we are winding down, this is not a time to back down. We recognize the deep importance of our mission and work amid attacks on Jewish people and LGBTQ people – and LGBTQ Jews at the intersection,” said A Wider Bridge in its letter. “Our board members remain committed to showing up in their individual capacities to represent queer Jews across diverse spaces — and we know our partners and supporters will continue to do the same.”
Editor’s note: Washington Blade International News Editor Michael K. Lavers traveled to Israel and Palestine with A Wider Bridge in 2016.
The White House
‘Trump Rx’ plan includes sharp cuts to HIV drug prices
President made announcement on Friday
President Donald Trump met with leaders from some of the world’s largest pharmaceutical companies at the White House on Friday to announce his new “Trump Rx” plan and outline efforts to reduce medication costs for Americans.
During the roughly 47-minute meeting in the Roosevelt Room, Trump detailed his administration’s efforts to cut prescription drug prices and make medications more affordable for U.S. patients.
“Starting next year, American drug prices will come down fast, furious, and will soon be among the lowest in the developed world,” Trump said during the meeting. “For decades, Americans have been forced to pay the highest prices in the world for prescription drugs by far … We will get the lowest price of anyone in the world.”
Trump signed an executive order in May directing his administration “to do everything in its power to slash prescription drug prices for Americans while getting other countries to pay more.”
“This represents the greatest victory for patient affordability in the history of American health care, by far, and every single American will benefit,” he added.
Several pharmaceutical executives stood behind the president during the announcement, including Sanofi CEO Paul Hudson, Novartis CEO Vas Narasimhan, Genentech CEO Ashley Magargee, Boehringer Ingelheim (USA) CEO Jean-Michel Boers, Gilead Sciences CEO Dan O’Day, Bristol Myers Squibb General Counsel Cari Gallman, GSK CEO Emma Walmsley, Merck CEO Robert Davis, and Amgen Executive Vice President Peter Griffith.
Also in attendance were Health and Human Services Secretary Robert F. Kennedy Jr., Commerce Secretary Howard Lutnick, Centers for Medicare and Medicaid Services Administrator Mehmet Oz, and Food and Drug Administration Commissioner Marty Makary.
Under the Trump Rx plan, the administration outlined a series of proposed drug price changes across multiple companies and therapeutic areas. Among them were reductions for Amgen’s cholesterol-lowering drug repatha from $573 to $239; Bristol Myers Squibb’s HIV medication reyataz from $1,449 to $217; Boehringer Ingelheim’s type 2 diabetes medication jentadueto from $525 to $55; Genentech’s flu medication xofluza from $168 to $50; and Gilead Sciences’ hepatitis C medication epclusa from $24,920 to $2,425.
Additional reductions included several GSK inhalers — such as the asthma inhaler advair diskus 500/50, from $265 to $89 — Merck’s diabetes medication januvia from $330 to $100, Novartis’ multiple sclerosis medication mayzent from $9,987 to $1,137, and Sanofi’s blood thinner plavix from $756 to $16. Sanofi insulin products would also be capped at $35 per month’s supply.
These prices, however, would only be available to patients who purchase medications directly through TrumpRx. According to the program’s website, TrumpRx “connects patients directly with the best prices, increasing transparency, and cutting out costly third-party markups.”
Kennedy spoke after Trump, thanking the president for efforts to lower pharmaceutical costs in the U.S., where evidence has shown that drug prices — including both brand-name and generic medications — are nearly 2.78 times higher than prices in comparable countries. According to the Pharmaceutical Research and Manufacturers of America, roughly half of every dollar spent on brand-name drugs goes to entities that play no role in their research, development, or manufacturing.
“This is affordability in action,” Kennedy said. “We are reversing that trend and making sure that Americans can afford to get the life-saving solutions.”
Gilead CEO Dan O’Day also spoke about how the restructuring of drug costs under TrumpRx, combined with emerging technologies, could help reduce HIV transmission — a virus that, if untreated, can progress to AIDS. The LGBTQ community remains disproportionately affected by HIV.
“Thank you, Mr. President — you and the administration,” O’Day said. “I think this objective of achieving the commitment to affordability and future innovation is extraordinary … We just recently launched a new medicine that’s only given twice a year to prevent HIV, and we’re working with Secretary Kennedy and his entire team, as well as the State Department, as a part of your strategy to support ending the epidemic during your term.
“I’ve never been more optimistic about the innovation that exists across these companies and the impact this could have on America’s health and economy,” he added.
Trump interjected, asking, “And that’s working well with HIV?”
“Yes,” O’Day replied.
“It’s a big event,” Trump said.
“It literally prevents HIV almost 100 percent given twice a year,” O’Day responded.
A similar anti-HIV medication is currently prescribed more than injectable form mentioned by O’Day. PrEP, is a medication regimen proven to significantly reduce HIV infection rates for people at high risk. Without insurance, brand-name Truvada can cost roughly $2,000 per month, while a generic version costs about $60 per month.
Even when medication prices are reduced, PrEP access carries additional costs, including clinic and laboratory fees, office visits, required HIV and sexually transmitted infection testing, adherence services and counseling, and outreach to potentially eligible patients and providers.
According to a 2022 study, the annual total cost per person for PrEP — including medication and required clinical and laboratory monitoring — is approximately $12,000 to $13,000 per year.
The TrumpRx federal platform website is now live at TrumpRx.gov, but the program is not slated to begin offering reduced drug prices until January.
The White House
EXCLUSIVE: Democracy Forward files FOIA lawsuit after HHS deadnames Rachel Levine
Trans former assistant health secretary’s name changed on official portrait
Democracy Forward, a national legal organization that works to advance democracy and social progress through litigation, policy and public education, and regulatory engagement, filed a lawsuit Friday in federal court seeking to compel the U.S. Department of Health and Human Services to release information related to the alteration of former Assistant Secretary for Health Adm. Rachel Levine’s official portrait caption.
The lawsuit comes in response to the slow pace of HHS’s handling of multiple Freedom of Information Act requests — requests that federal law requires agencies to respond to within 20 working days. While responses can take longer due to backlogs, high request volumes, or the need for extensive searches or consultations, Democracy Forward says HHS has failed to provide any substantive response.
Democracy Forward’s four unanswered FOIA requests, and the subsequent lawsuit against HHS, come days after someone in the Trump-Vance administration changed Levine’s official portrait in the Hubert H. Humphrey Building to display her deadname — the name she used before transitioning and has not used since 2011.
According to Democracy Forward, HHS “refused to release any records related to its morally wrong and offensive effort to alter former Assistant Secretary for Health Admiral Rachel Levine’s official portrait caption.” Levine was the highest-ranking openly transgender government official in U.S. history and served as assistant secretary for health and as an admiral in the U.S. Public Health Service Commissioned Corps from 2021 to 2025.
Democracy Forward President Skye Perryman spoke about the need to hold the Trump-Vance administration accountable for every official action, especially those that harm some of the most targeted Americans, including trans people.
“The question every American should be asking remains: what is the Trump-Vance administration hiding? For an administration that touts its anti-transgender animus and behavior so publicly, its stonewalling and silence when it comes to the people’s right to see public records about who was behind this decision is deafening,” Perryman said.
“The government’s obligation of transparency doesn’t disappear because the information sought relates to a trailblazing former federal official who is transgender. It’s not complicated — the public is entitled to know who is making decisions — especially decisions that seek to alter facts and reality, erase the identity of a person, and affect the nation’s commitment to civil rights and human dignity.”
“HHS’s refusal to respond to these lawful requests raises more serious concerns about transparency and accountability,” Perryman added. “The public has every right to demand answers — to know who is behind this hateful act — and we are going to court to get them.”
The lawsuit also raises questions about whether the alteration violated federal accuracy and privacy requirements governing Levine’s name, and whether the agency improperly classified the change as an “excepted activity” during a lapse in appropriations. By failing to make any determination or produce any records, Democracy Forward argues, HHS has violated its obligations under federal law.
The case, Democracy Forward Foundation v. U.S. Department of Health and Human Services, was filed in the U.S. District Court for the District of Columbia. The legal team includes Anisha Hindocha, Daniel McGrath, and Robin Thurston.
The Washington Blade reached out to HHS, but has not received any comment.
The lawsuit and four FOIA requests are below:
‘Dogs of Venice’ looks at love lost and rediscovered
A Wider Bridge to close
‘Trump Rx’ plan includes sharp cuts to HIV drug prices
Rehoboth’s Blue Moon is for sale but owners aim to keep it in gay-friendly hands
Comings & Goings
LGBTQ Democrats say they’re ready to fight to win in 2026
Brian Footer suspends campaign for Ward 1 D.C. Council seat
Lighting candles in a time of exhaustion
Why queer spaces often fail South Asian women
